Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.
Atorvastatin is a statin: it blocks HMG-CoA reductase, the liver enzyme that makes cholesterol, so the liver pulls more LDL cholesterol out of the blood. It is used to lower cholesterol and to reduce the chance of heart attack and stroke. It is sold as Lipitor, among other names.
SLCO1B1 makes a transporter that carries statins from the blood into the liver, where they work. A common variant (rs4149056, part of the *5 and *15 versions) makes the transporter less effective, so more atorvastatin stays in the blood, which is linked to a higher chance of statin muscle pain and weakness. CPIC and DPWG have published guidelines on SLCO1B1 and atorvastatin, and the US FDA lists an effect on drug levels. Studies have also looked at CYP3A4 and CYP3A5, which break atorvastatin down, and at genes linked to how much cholesterol falls, with weaker evidence.
Clinical guidelines that name a gene for Atorvastatin. They sort people into groups by the gene copies they carry.
Every published finding on gene variants and Atorvastatin. Upload your DNA file to see which of these rows apply to you.
PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.
SLCO1B1 SLCO1B1*1, SLCO1B1*5, SLCO1B1*15: Level 1A · replicated. Toxicity. 20.
SLCO1B1 rs4149056: Level 1A · replicated. Metabolism/PK. 18.
SLCO1B1 rs4149056: Level 1A · replicated. Toxicity: statin-related myopathy. 17.
SLCO1B1 SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37: Level 1A · replicated. Metabolism/PK. 9.
Studies of how quickly the body processes this medication.
Studies of how well it worked in people carrying a variant.
Studies that do not fall into the groups above.
Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.
More drugs from the same category
Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.
Content updated September 2026.
ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.
Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026
Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com